Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Amrapali Hospital...

    Amrapali Hospital Auction: Only One Single bid of Rs 13.74 crore made, rejected

    GarimaWritten by Garima Published On 2019-03-27T16:55:13+05:30  |  Updated On 27 March 2019 4:55 PM IST
    Amrapali Hospital Auction: Only One Single bid of Rs 13.74 crore made, rejected

    New Delhi: Troubled Amrapali Group is in for another setback as the Debt Recovery Tribunal (DRT) has rejected the LONE BID of Rs 13.74 crore that was made to purchase the 40-bedded Amrapali hospital owned by the group in Noida. The tribunal was directed by the Supreme Court to auction properties of the group.


    For the auction of the same, the tribunal had fixed a base price of Rs 13.73 crore. Seeing that just a single bid came for the hospital, that too of just a marginally higher amount of Rs 13.74 crore, the tribunal turned down the bid stating that the price was insufficient while also expressing apprehensions of possible cartelization to ensure the property is sold at a cheap rate.


    Amrapali Group, a known real estate chain in the past had expanded its business across 30 cities in the country and more than 50 housing and commercial projects. However, the downfall of the group was seen as various controversies sparked. I


    Medical Dialogues had earlier reported that in late 2018, in a massive crackdown on Amrapali Group for “wilful disobedience” of its orders, the Supreme Court on had attached the company’s 100-bed multi-speciality hospital, bank accounts, the building which houses its office, certain firms and a “benami” Villa in Goa.


    Also Read: Supreme Court Orders Attachment of 100 bedded Amrapali Hospital, other properties of Amrapali Group


    With the auction process of the hopsital on, a lone bid was made by Dr Ajau Kohli and M/s Promhex Plus Healthcare Pvt Ltd to purchase the hospital against the base price of Rs 13.73 crore fixed by the tribunal. The tribunal came to the conclusion that the market value of the property was at least Rs 16 crore and rejected the bid.


    According to a report by TOI, the tribunal said, “Taking note of the facts that the said property is a hospital having 40 beds and fully equipped, certainly more bids might have been turned up but the same has been withheld by some unscrupulous persons, therefore, prima facie it appears that cartelisation is at work ... The price of the said property is not adequate.”

    40-bed hospitalAmrapaliAmrapali GroupAmrapali HospitalbidcartelisationDebt Recovery Tribunalhealth newshospital in Noidamedical newsNoidaRejectedSCsoldToday news Delhi
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok